Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
NanoViricides' President delivers speech at ASNM Second Annual Conference

NanoViricides' President delivers speech at ASNM Second Annual Conference

HSV1716 clinical trial for childhood cancer receives FDA grant

HSV1716 clinical trial for childhood cancer receives FDA grant

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

Condoms can prevent transmission of herpes simplex virus 2: Study

Condoms can prevent transmission of herpes simplex virus 2: Study

NanoViricides' anti-Herpes drug candidates demonstrate significant efficacy in cell culture studies

NanoViricides' anti-Herpes drug candidates demonstrate significant efficacy in cell culture studies

Vical second-quarter revenues decrease to $2.1 million

Vical second-quarter revenues decrease to $2.1 million

DIATHERIX Laboratories opens rapid response diagnostic panels for STD, HSV

DIATHERIX Laboratories opens rapid response diagnostic panels for STD, HSV

Antigenics announces positive results of AG-707 genital herpes vaccine

Antigenics announces positive results of AG-707 genital herpes vaccine

Scientists discover mechanism of herpes virus cell entry machinery

Scientists discover mechanism of herpes virus cell entry machinery

Vical's prophylactic Vaxfectin-formulated pDNA vaccine effective against HSV-2 in animal model

Vical's prophylactic Vaxfectin-formulated pDNA vaccine effective against HSV-2 in animal model

Researchers make scientific breakthrough in fight against HIV, genital herpes with a vaginal gel

Researchers make scientific breakthrough in fight against HIV, genital herpes with a vaginal gel

Fatness drives inactivity, not the other way around

Fatness drives inactivity, not the other way around

Map of herpes virus "cell-entry machinery" provides new target for antiviral drugs

Map of herpes virus "cell-entry machinery" provides new target for antiviral drugs

LEAPS vaccine technology generates dendritic cells to stimulate immune system to fight viral illnesses

LEAPS vaccine technology generates dendritic cells to stimulate immune system to fight viral illnesses

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

HSV-1 may cause cognitive deficits: Study

HSV-1 may cause cognitive deficits: Study

FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

NanoViricides signs research and development agreement with Dr. Ken S. Rosenthal's laboratory

NanoViricides signs research and development agreement with Dr. Ken S. Rosenthal's laboratory

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Scientists discover human DNA that act as a traitor to body's defences

Scientists discover human DNA that act as a traitor to body's defences